Literature DB >> 31019761

Prognostic significance of preoperative lymph node assessment for patients with stage pN0 esophageal squamous cell carcinoma after esophagectomy.

Yan Shi1, Jinming Xu1, Ying Wang2, Jie Tang1, Chong Zhang1, Wang Lv1, Jian Hu1.   

Abstract

BACKGROUND: Accurate preoperative lymph node (LN) staging is important for surgical treatments of esophageal squamous cell carcinoma (ESCC). The aim of the study was to investigate the role of preoperative lymph nodes assessment by computed tomography (CT) scans in prognostic estimates and lymph nodes dissection strategy.
METHODS: A total of 233 stage pN0 ESCC patients who underwent radical esophagectomy from 2009 to 2016 were included, with the last follow-up time in 2018. Survival analysis was conducted to assess the relationship between preoperative clinical LN metastasis and the prognosis of patients with pN0 ESCC.
RESULTS: Ninety-nine patients were classified as clinical positive LN metastasis by CT scans, but were confirmed as stage N0 by postoperative pathological examination, and survival analysis suggested that these patients had relatively poorer prognosis (P=0.027). Cox regression analysis indicated that the clinical LN metastasis on CT scans was an independent negative prognostic factor for patients with pN0 ESCC (P=0.031). The number of LNs dissected affected the prognosis of pN0 patients. Patients with positive LN metastasis on CT would have better prognosis when the number of dissected LNs was equal to or more than 15 LNs (P=0.036). Especially for patients with higher T stage, they were would obtain prognostic benefit with at least 17 LNs dissected (P=0.037). On the other hand, for those with negative LN metastasis on CT, at least 12 LNs dissected indicated better prognosis (P=0.019).
CONCLUSIONS: Preoperative LN assessment for ESCC patients is critically important, the optimal LN dissection number should refer to the preoperative CT performance.

Entities:  

Keywords:  CT scan; Esophageal squamous cell carcinoma; lymph nodes dissection

Year:  2019        PMID: 31019761      PMCID: PMC6462721          DOI: 10.21037/jtd.2019.02.25

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  23 in total

1.  How many lymph nodes are needed for an accurate pN classification in esophageal cancer? Evidence for a new threshold value.

Authors:  Philipp Dutkowski; Gerhard Hommel; Thomas Böttger; Tilmann Schlick; Theo Junginger
Journal:  Hepatogastroenterology       Date:  2002 Jan-Feb

2.  Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer.

Authors:  Jeongmin Choi; Sang Gyun Kim; Joo Sung Kim; Hyun Chae Jung; In Sung Song
Journal:  Surg Endosc       Date:  2009-12-24       Impact factor: 4.584

3.  Ratio of metastatic lymph nodes to total number of nodes resected is prognostic for survival in esophageal carcinoma.

Authors:  Clive J Kelty; Catherine W Kennedy; Gregory L Falk
Journal:  J Thorac Oncol       Date:  2010-09       Impact factor: 15.609

4.  An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China.

Authors:  Hao-Xian Yang; Ying Xu; Jian-Hua Fu; Jun-Ye Wang; Peng Lin; Tie-Hua Rong
Journal:  Ann Surg Oncol       Date:  2010-02-10       Impact factor: 5.344

5.  Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.

Authors:  Hiroyuki Kato; Hiroyuki Kuwano; Masanobu Nakajima; Tatsuya Miyazaki; Minako Yoshikawa; Hitoshi Ojima; Katsuhiko Tsukada; Noboru Oriuchi; Tomio Inoue; Keigo Endo
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

6.  X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

Authors:  Robert L Camp; Marisa Dolled-Filhart; David L Rimm
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

7.  The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.

Authors:  Patrick R Pfau; Scott B Perlman; Peter Stanko; Terrence J Frick; Deepak V Gopal; Adnan Said; Zhengjun Zhang; Tracey Weigel
Journal:  Gastrointest Endosc       Date:  2007-03       Impact factor: 9.427

8.  Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.

Authors:  Andrew P Barbour; Nabil P Rizk; Mithat Gonen; Laura Tang; Manjit S Bains; Valerie W Rusch; Daniel G Coit; Murray F Brennan
Journal:  Ann Surg Oncol       Date:  2006-11-08       Impact factor: 5.344

9.  Clinical impact of lymphadenectomy extent in resectable esophageal cancer.

Authors:  Roderich E Schwarz; David D Smith
Journal:  J Gastrointest Surg       Date:  2007-09-02       Impact factor: 3.452

10.  How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma?

Authors:  Yang Hu; Chunyan Hu; Helin Zhang; Yumin Ping; Long-Qi Chen
Journal:  Ann Surg Oncol       Date:  2009-12-02       Impact factor: 5.344

View more
  2 in total

1.  Impact of postoperative lymph node status on the prognosis of esophageal squamous cell carcinoma after esophagectomy following neoadjuvant chemoradiotherapy: a retrospective study.

Authors:  Zhiyong Sun; Xin Xu; Xiaojing Zhao; Xiumei Ma; Qing Ye
Journal:  J Gastrointest Oncol       Date:  2021-12

2.  Risk factors for lymph node metastasis of the left recurrent laryngeal nerve in patients with esophageal squamous cell carcinoma.

Authors:  Chuangui Chen; Zhao Ma; Xiaobin Shang; Xiaofeng Duan; Jie Yue; Hongjing Jiang
Journal:  Ann Transl Med       Date:  2021-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.